Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ADH1B | P00325 | 1/20 | 0.30 |
| ▸ | ADH1C | P00326 | 1/20 | 0.30 |
| ▸ | ADH1A | P07327 | 1/20 | 0.30 |
| ▸ | ADH4 | P08319 | 1/20 | 0.30 |
| ▸ | ADH7 | P40394 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5565696 | 1.00 | GPR84 (0.33) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL217501 | 0.67 | ACHE (0.35) | LMNA | |
| SCHEMBL8973370 | 0.66 | OPRM1 (0.39) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL8973592 | 0.66 | OPRM1 (0.39) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL8973166 | 0.66 | OPRM1 (0.39) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL6684351 | 0.65 | SLC2A1 (0.44) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL9137197 | 0.65 | SLC2A1 (0.44) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL6765730 | 0.64 | OPRM1 (0.38) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL6907025 | 0.64 | GPR84 (0.35) | GPR84OPRM1SPHK1LMNAADH1B | |
| SCHEMBL6678858 | 0.62 | OPRM1 (0.44) | GPR84OPRM1SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421921-B2 | Lubricants from mixed alpha-olefin feeds | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-09-24 | — | — | US | disclosed |
| EP-1920031-B1 | LUBRICANTS FROM MIXED ALPHA-OLEFIN FEEDS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2018-01-10 | — | — | EP | disclosed |
| US-20170137737-A1 | Lubricants from Mixed Alpha-Olefin Feeds | EXXONMOBIL CHEMICAL PATENTS INC. | 2017-05-18 | — | — | US | disclosed |
| US-9593288-B2 | Lubricants from mixed alpha-olefin feeds | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-03-14 | — | — | US | disclosed |
| US-9409834-B2 | Low viscosity poly-alpha-olefins | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-08-09 | — | — | US | disclosed |
| US-20150252279-A1 | Lubricants From Mixed Alpha-Olefin Feeds | EXXONMOBIL CHEMICAL PATENTS INC. | 2015-09-10 | — | — | US | disclosed |
| US-8957159-B2 | Multiple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8921291-B2 | Lubricants from mixed alpha-olefin feeds | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-12-30 | — | — | US | disclosed |
| US-20140378720-A1 | Processes to Produce Polyalpha-Olefin Compositions | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-12-25 | — | — | US | disclosed |
| EP-1910432-B1 | PROCESS TO PRODUCE LOW VISCOSITY POLY-ALPHA-OLEFINS | EXXONMOBIL CHEM PATENTS INC (US) | 2014-11-12 | — | — | EP | disclosed |
| US-20090036725-A1 | Process To Produce Polyalphaolefins | EXXONMOBIL CHEMICAL PATENTS INC. | 2009-02-05 | — | — | US | disclosed |
| WO-2009017953-A2 | PROCESS TO PRODUCE POLYALPHAOLEFINS | EXXONMOBIL CHEMICAL PATENT INC. (US) | 2009-02-05 | — | — | WO | disclosed |
| US-20090005279-A1 | Polyalpha-Olefin Compositions and Processes to Produce the Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2009-01-01 | — | — | US | disclosed |
| WO-2008140875-A1 | CATALYST SYSTEM FOR OLEFIN POLYMERIZATION AND POLYMERS PRODUCED THEREFROM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-11-20 | — | — | WO | disclosed |
| US-20080287617-A1 | Catalyst System For Olefin Polymerization And Polymers Produced Therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-11-20 | — | — | US | disclosed |
| US-20080177121-A1 | Process to produce high viscosity fluids | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-07-24 | — | — | US | disclosed |
| US-20070293640-A1 | Multiple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-12-20 | — | — | US | disclosed |
| US-7294681-B2 | Mutliple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-11-13 | — | — | US | disclosed |
| US-7223822-B2 | Multiple catalyst and reactor system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-05-29 | — | — | US | disclosed |
| US-20070043248-A1 | Process to produce low viscosity poly-alpha-olefins | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036725-A1 | Process To Produce Polyalphaolefins | KCNMA1, F10, AP2A1 | GPR84 2009/4885OPRM1 662/4885SPHK1 2398/4885 |
| US-20070043248-A1 | Process to produce low viscosity poly-alpha-olefins | AP1M1, AP3D1, AP3M1 | GPR84 4301/4885OPRM1 343/4885SPHK1 2879/4885 |
| US-20080177121-A1 | Process to produce high viscosity fluids | SCO2, POLI, TAOK1 | GPR84 2067/4885OPRM1 670/4885SPHK1 1849/4885 |
| US-20140378720-A1 | Processes to Produce Polyalpha-Olefin Compositions | AP1M1, AP1S1, CCT4 | GPR84 2159/4885OPRM1 58/4885SPHK1 1081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.